Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children
Clinical trial NCT04484935 · COMPLETED
Trial details
- NCT number
- NCT04484935
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-19
- Primary completion
- 2023-02-17
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.